More on Medicis Pharmaceutical (MRX): Q3 misses estimates across the board. Revenue grew an anemic 4% Y/Y as the company was hit by higher R&D and promotional costs associated with marketing.

The Suzy MRX Advisory Board will offer expertise to inform the overarching company strategy and focus, as well as provide input into the development of new products and research capabilities.

Says MRX-5LBT is a new type of medication that uses the ILTS (Ionic Liquid Transdermal System), an exclusive MEDRx technology that incorporates the company's ionic liquid expertise * Says the ...